Media Center

Press Releases


Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting

3 April 2024/by webadmin

Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)

20 November 2023/by webadmin

Astex CSO David Rees Honoured as a Hero of Chemistry by the American Chemical Society

13 October 2023/by webadmin

Astex Expands Drug Discovery Collaboration With MSD

8 August 2023/by webadmin

Astex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases

13 February 2023/by webadmin

Astex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours

31 December 2022/by webadmin

British Company Behind Groundbreaking Breast Cancer Treatment

7 June 2019/by webadmin

Astex Pharmaceuticals Celebrates as Second New Cancer Drug Receives US Marketing Approval

12 April 2019/by webadmin

Astex’s Harren Jhoti Made Fellow of the Royal Society

9 May 2018/by webadmin

Astex Continues to Deliver in Oncology as Erdafitinib, a Potential New Treatment for Metastatic Urothelial Cancer, Receives US FDA Breakthrough Therapy Designation

15 March 2018/by webadmin

Harren Jhoti Receives Lifetime Achievement Award from the UK BioIndustry Association

26 January 2018/by webadmin

Otsuka Signs Statement of Support for Women’s Empowerment Principles

19 January 2018/by Peggy Bickerton

Astex Pharmaceuticals Celebrates as Cancer Drug Receives Marketing Approval in Europe

24 August 2017/by Peggy Bickerton

Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval

13 March 2017/by Peggy Bickerton

Selected past releases are archived for your reference.